首页> 外文期刊>European journal of pain : >Annexin 1; A glycocorticoid-inducibie protein that modylates inflammatory pain
【24h】

Annexin 1; A glycocorticoid-inducibie protein that modylates inflammatory pain

机译:膜联蛋白1;糖皮质激素诱导蛋白,可改变炎症性疼痛

获取原文
获取原文并翻译 | 示例
           

摘要

Annexin 1, a glucocorticoid (GC)-indudble protein, can play an important role via formyl peptide receptor like 1 (FPR2/ALX, also known as FPRL1) in inflammatory pain modulation. The aim of this review is to analyze different lines of evidence for the role of ANXA1 with different mechanisms on inflammatory pain and describe the profile of ANXA1 as a potential analgesic. A Medline (PUBMED) search using the terms 'Annexin 1 distribution OR expression, FPR2/ALX distribution OR expression, Annexin 1 AND pain, Annexin 1 AND FPR2/ALX AND pain' was performed. Articles with a publication date up to Nov. 1st, 2012 were included. The antinociception of ANXA1 has been evaluated in diverse pain models. It has been suggested that ANXA1 may exerts its action via: (1) inhibiting vital cytokines involved in pain transmission, (2) inhibiting neutrophil accumulation through preventing transendothelial migration via an interaction with formyl peptide receptors, (3) facilitating tonic opioid release from neutrophil in inflammatory site, (4) interrupting the peripheral nociceptive transmission by suppressing neuronal excitability. In general, ANXA1 is a potential mediator for anti-nociception and the role with its receptor constitute attractive targets for developing anesthesia and analgesic drugs, and their interaction may prove to be a useful strategy to treat inflammatory pain.
机译:膜联蛋白1是一种糖皮质激素(GC)抑制性蛋白,可通过甲酰肽受体1(FPR2 / ALX,也称为FPRL1)在炎症性疼痛调节中发挥重要作用。这篇综述的目的是分析具有不同机制对ANXA1的炎性疼痛作用的不同证据,并描述ANXA1作为一种潜在的镇痛药的概况。使用术语“附件1分布或表达,FPR2 / ALX分布或表达,膜联蛋白1和疼痛,膜联蛋白1和FPR2 / ALX和疼痛”进行了Medline(PUBMED)搜索。包括发布日期截止至2012年11月1日的文章。 ANXA1的抗伤害感受作用已在多种疼痛模型中进行了评估。有人提出,ANXA1可能通过以下方式发挥作用:(1)抑制疼痛传递所涉及的重要细胞因子;(2)通过与甲酰肽受体的相互作用阻止内皮跨膜迁移,从而抑制中性粒细胞积聚;(3)促进中性粒细胞释放补体阿片在炎性部位,(4)通过抑制神经元兴奋性来中断周围的伤害感受传递。通常,ANXA1是潜在的抗伤害感受性介质,其受体的作用构成了开发麻醉药和镇痛药的诱人靶标,它们的相互作用可能被证明是治疗炎症性疼痛的有用策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号